News
Press Releases & Media
Latest updates from Carvolix and our portfolio companies.
Carvolix is born and funded
Press Release
Carvolix is born and funded
February 2026
Caranx Medical announces first clinical use of the TAVIPILOT Soft, cleared by FDA for commercial in July: the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.
Press Release
Caranx Medical announces first clinical use of the TAVIPILOT Soft, cleared by FDA for commercial in July: the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation.
February 2026
Caranx Medical (Carvolix project company) announces first clinical use in patients of the TAVIPILOT Robot at Macquarie University Hospital, Sydney, Australia
Press Release
Caranx Medical (Carvolix project company) announces first clinical use in patients of the TAVIPILOT Robot at Macquarie University Hospital, Sydney, Australia
February 2026
Carvolix appoints Liane Teplitsky as a new member of the Board of Directors
Press Release
Carvolix appoints Liane Teplitsky as a new member of the Board of Directors
April 2025
Presentation at LSI Europe ’24
Emerging MedTech Summit 2024 (Lisbon)
Sébastien Ladet, CEO
Video
Presentation at LSI Europe ’24
Presentation at LSI Europe ’24
Emerging MedTech Summit 2024 (Lisbon)
Sébastien Ladet, CEO
November 2024
Interview with Dr. Sarraf
Epygon: A unique device for mitral valve repair
Video
Interview with Dr. Sarraf
Interview with Dr. Sarraf
Epygon: A unique device for mitral valve repair
October 2024